{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T16:12:36Z","timestamp":1775923956666,"version":"3.50.1"},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T00:00:00Z","timestamp":1497225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T00:00:00Z","timestamp":1497225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1111\/ane.12783","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T03:22:39Z","timestamp":1497324159000},"page":"660-667","source":"Crossref","is-referenced-by-count":33,"title":["Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation"],"prefix":"10.1155","volume":"136","author":[{"given":"V.","family":"Rispoli","sequence":"first","affiliation":[{"name":"Neurology Department; Az. Ospedaliero-Universitaria Arcispedale Sant'Anna; Cona Ferrara Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Simioni","sequence":"additional","affiliation":[{"name":"Neurology Department; Az. Ospedaliero-Universitaria Arcispedale Sant'Anna; Cona Ferrara Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G.","family":"Capone","sequence":"additional","affiliation":[{"name":"Neurology Department; Az. Ospedaliero-Universitaria Arcispedale Sant'Anna; Cona Ferrara Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Golfr\u00e8 Andreasi","sequence":"additional","affiliation":[{"name":"Neurology Department; Az. Ospedaliero-Universitaria Arcispedale Sant'Anna; Cona Ferrara Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Preda","sequence":"additional","affiliation":[{"name":"Neurology Department; Ospedale Bufalini; Cesena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sette","sequence":"additional","affiliation":[{"name":"Neurology Department; Az. Ospedaliero-Universitaria Arcispedale Sant'Anna; Cona Ferrara Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Tugnoli","sequence":"additional","affiliation":[{"name":"Neurology Department; Az. Ospedaliero-Universitaria Arcispedale Sant'Anna; Cona Ferrara Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6434-5433","authenticated-orcid":false,"given":"M.","family":"Sensi","sequence":"additional","affiliation":[{"name":"Neurology Department; Az. Ospedaliero-Universitaria Arcispedale Sant'Anna; Cona Ferrara Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,6,12]]},"reference":[{"key":"10.1111\/ane.12783-BIB0001|ane12783-cit-0001","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","article-title":"Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study","volume":"13","author":"Olanow","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.12783-BIB0002|ane12783-cit-0002","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.parkreldis.2012.06.022","article-title":"Duodopa\u00ae treatment for advanced Parkinson's disease: a review of efficacy and safety","volume":"18","author":"Nyholm","year":"2012","journal-title":"Park Relat Disord"},{"key":"10.1111\/ane.12783-BIB0003|ane12783-cit-0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0066639","article-title":"Neuropathy in Parkinson's disease patients with intestinal Levodopa infusion versus oral drugs","volume":"8","author":"Jugel","year":"2013","journal-title":"PLoS One"},{"key":"10.1111\/ane.12783-BIB0004|ane12783-cit-0004","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/mds.23342","article-title":"Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy","volume":"25","author":"Urban","year":"2010","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12783-BIB0005|ane12783-cit-0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00702-011-0689-3","article-title":"Malnutritional neuropathy under intestinal levodopa infusion","volume":"119","author":"Klostermann","year":"2012","journal-title":"J Neural Transm"},{"key":"10.1111\/ane.12783-BIB0006|ane12783-cit-0006","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00415-011-6396-z","article-title":"Valldeoriololyneuropathy while on duodenal levodopa infusion in Parkinson's disease patients: we must be alert","volume":"259","author":"Santos-Garc\u00eda","year":"2012","journal-title":"J Neurol"},{"key":"10.1111\/ane.12783-BIB0007|ane12783-cit-0007","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.parkreldis.2013.02.006","article-title":"Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery","volume":"19","author":"M\u00fcller","year":"2013","journal-title":"Park Relat Disord"},{"key":"10.1111\/ane.12783-BIB0008|ane12783-cit-0008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.parkreldis.2016.01.026","article-title":"The peripheral nerve involvement in Parkinson Disease: A multifaceted phenomenon","volume":"25","author":"Cossu","year":"2016","journal-title":"Park Relat Disord"},{"key":"10.1111\/ane.12783-BIB0009|ane12783-cit-0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ane.12164","article-title":"Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients","volume":"129","author":"Merola","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12783-BIB0010|ane12783-cit-0010","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00702-014-1204-4","article-title":"Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation","volume":"121","author":"Lehnerer","year":"2014","journal-title":"J Neural Transm"},{"key":"10.1111\/ane.12783-BIB0011|ane12783-cit-0011","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/ene.12846","article-title":"Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment","volume":"23","author":"Merola","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.12783-BIB0012|ane12783-cit-0012","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.parkreldis.2016.04.016","article-title":"Levodopa and neuropathy risk in patients with Parkinson disease: effect of COMT inhibition","volume":"27","author":"Cossu","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1111\/ane.12783-BIB0013|ane12783-cit-0013","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/jnnp-2014-308586","article-title":"Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management","volume":"86","author":"Uncini","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12783-BIB0014|ane12783-cit-0014","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2013.09.007","article-title":"Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens","volume":"20","author":"Mancini","year":"2014","journal-title":"Park Relat Disord"},{"key":"10.1111\/ane.12783-BIB0015|ane12783-cit-0015","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/mds.22137","article-title":"Neuropathy as a potential complication of levodopa use in Parkinson's disease","volume":"23","author":"Toth","year":"2008","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12783-BIB0016|ane12783-cit-0016","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00702-011-0614-9","article-title":"Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa\/carbidopa gel","volume":"118","author":"M\u00fcller","year":"2011","journal-title":"J Neural Transm"},{"key":"10.1111\/ane.12783-BIB0017|ane12783-cit-0017","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/mds.22807","article-title":"Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy","volume":"24","author":"Manca","year":"2009","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12783-BIB0018|ane12783-cit-0018","first-page":"10","article-title":"Which patients discontinue? Issues on Levodopa\/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up","author":"Sensi","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1111\/ane.12783-BIB0019|ane12783-cit-0019","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archneur.60.9.1296","article-title":"Challenges in the identification of cobalamin-deficiency polyneuropathy","volume":"60","author":"Saperstein","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.12783-BIB0020|ane12783-cit-0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00702-013-1153-3","article-title":"Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients","volume":"121","author":"Sensi","year":"2014","journal-title":"J Neural Transm"},{"key":"10.1111\/ane.12783-BIB0021|ane12783-cit-0021","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0148607112440285","article-title":"Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition)","volume":"36","author":"White","year":"2012","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1111\/ane.12783-BIB0022|ane12783-cit-0022","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/dmrr.1226","article-title":"Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity","volume":"27","author":"Dyck","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1111\/ane.12783-BIB0023|ane12783-cit-0023","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","article-title":"Neuropathy in Parkinson disease Prevalence and determinants","volume":"77","author":"Rajabally","year":"2011","journal-title":"Neurology"},{"key":"10.1111\/ane.12783-BIB0024|ane12783-cit-0024","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.25585","article-title":"Neuropathy and Levodopa in Parkinson's disease : evidence from a multicenter study","volume":"28","author":"Ceravolo","year":"2013","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12783-BIB0025|ane12783-cit-0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.22021","article-title":"Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease","volume":"68","author":"Toth","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12783-BIB0026|ane12783-cit-0026","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.parkreldis.2014.10.010","article-title":"Peripheral nervous system involvement in Parkinson\u2019 s disease : evidence and controversies","volume":"20","author":"Comi","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1111\/ane.12783-BIB0027|ane12783-cit-0027","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ana.22330","article-title":"Neuropathy in idiopathic Parkinson disease: an iatrogenic problem?","volume":"69","author":"Nolano","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12783-BIB0028|ane12783-cit-0028","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12883-016-0667-3","article-title":"Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism","volume":"16","author":"Ara\u00fajo","year":"2016","journal-title":"BMC Neurol"},{"key":"10.1111\/ane.12783-BIB0029|ane12783-cit-0029","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1212\/WNL.0000000000000973","article-title":"Skin nerve alpha-synuclein deposits: a biomarker for idiopathic Parkinson disease","volume":"83","author":"Donadio","year":"2014","journal-title":"Neurology"},{"key":"10.1111\/ane.12783-BIB0030|ane12783-cit-0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/mds.23408","article-title":"Transcutaneous port for continuous duodenal levodopa\/carbidopa administration in Parkinson's disease","volume":"26","author":"Meppelink","year":"2011","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12783-BIB0031|ane12783-cit-0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ane.12464","article-title":"Transcutaneous port for levodopa\/carbidopa intestinal gel administration in Parkinson's disease","volume":"133","author":"Laar","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12783-BIB0032|ane12783-cit-0032","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/mus.25377","article-title":"Levodopa\/carbidopa intestinal gel therapy for advanced Parkinson disease: an early toxic effect for small nerve fibers?","volume":"54","author":"Devigili","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1111\/ane.12783-BIB0033|ane12783-cit-0033","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1574-6941.2011.01279.x","article-title":"Effect of a synbiotic on microbial community structure in a continuous culture model of the gastric microbiota in enteral nutrition patients","volume":"80","author":"Smith","year":"2012","journal-title":"FEMS Microbiol Ecol"},{"key":"10.1111\/ane.12783-BIB0034|ane12783-cit-0034","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00228-008-0532-4","article-title":"Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson's disease","volume":"64","author":"Adams","year":"2008","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12783","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12783\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:50:31Z","timestamp":1671540631000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12783","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6,12]]}}}